Portfolio (Quarterly)
Guide ↗
Avoro Capital Advisors LLC
· CIK 0001633313| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | ASCENDIS PHARMA | — | 5,062,500.0 | $1.16B | 11.39% | -49K | -0.9% | $228.73 | — |
| 2 | CNTA | CENTESSA PHARMACEUTICALS PLC | Healthcare | 11,430,455.0 | $454.0M | 4.47% | -3.1M | -21.5% | $39.72 | +0.4% |
| 3 | QURE | UNIQURE NV | Healthcare | 5,959,595.0 | $97.4M | 0.96% | -190K | -3.1% | $16.35 | +194.6% |
| 4 | — | SOLENO THERAPEUTICS INC | — | 2,300,000.0 | $77.0M | 0.76% | -600K | -20.7% | $33.48 | — |
| 5 | ALKS | ALKERMES PLC | Healthcare | 1,200,000.0 | $42.4M | 0.42% | -200K | -14.3% | $35.36 | +25.9% |
| 6 | LXEO | LEXEO THERAPEUTICS INC | Healthcare | 1,875,000.0 | $10.8M | 0.11% | -1.4M | -43.2% | $5.74 | -13.2% |
| 7 | MNKD | MANNKIND CORP | Healthcare | 2,200,000.0 | $5.4M | 0.05% | -2.2M | -50.5% | $2.45 | +60.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%